Here's a good article on the connection between chronic obstructive pulmonary disease (COPD) and atrial fibrillation. If you have COPD, here's where you can Get Started Learning About Atrial Fibrillation.
Read MoreYearly Archives: 2010
New medical guidelines from the European Society of Cardiology (ESC) incorporating the latest afib research put Europe ahead of the U.S. when it comes to standardized treatment of atrial fibrillation. Stroke prevention and symptom relief are at the heart of the new ESC guidelines, which also make it clear that the risk of stroke for …
Read More
On the heels of the US FDA approving dabigatran, the long-awaited alternative to Coumadin (warfarin), comes word that Health Canada has as well. In Canada, dabigatran is known as PRADAX™. Because this is the first alternative to warfarin in Canada, it is big news for the afib community there. Learn more at: Health Canada Approves …
Read More
October 29 is World Stroke Day. You can learn more about steps you can take to prevent a stroke at World Stroke Day, October 29, 2010. Professor Bo Norrving, president of the sponsoring World Stroke Organization, is a member of our StopAfib.org Medical Advisory Board.
Read More
The long-awaited alternative to Coumadin (warfarin) has just been approved by the US FDA. The FDA just approved Pradaxa (dabigatran) for use by those with atrial fibrillation for preventing afib-related strokes. The FDA based approval on results of the RE-LY trial, which saw patients on Pradaxa having fewer strokes than those on warfarin. And Pradaxa …
Read More
A new mini maze procedure developed by Dr. John Sirak at Ohio State University is a promising new treatment for persistent atrial fibrillation as it closely replicates the "gold standard" Cox Maze III lesion set in the heart's left atrium. This “five box” thoracoscopic maze procedure may be better able to treat persistent AF specifically …
Read More
The AFib STROKE Survey (Atrial Fibrillation Survey to Reveal Opinions, Knowledge & Education gaps) was premiered at the FacingAFib launch last week. Now you are invited to a Webinar in which atrial fibrillation experts will share the results of this AFib STROKE Survey. These experts will discuss the common misunderstandings that many patients hold about …
Read More
StopAfib.org is excited to announce our participation in FacingAFib, partnering with daytime TV star Susan Lucci, her husband Helmut Huber, Boehringer Ingelheim Pharmaceuticals, Inc., and the National Stroke Association. FacingAFib (www.FacingAFib.com) is a new national education program to improve awareness of Afib and its increased risk of stroke. To learn more, see: TV Star Susan …
Read More
An FDA panel today unanimously recommended that the FDA approve dabigatran (Pradaxa) for reducing the risk of afib strokes. FDA approval is expected quickly, making this the first alternative to warfarin approved in the United States, and also the first atrial fibrillation approval for dabigatran. It is approved in over 70 countries for venous thromboembolisms …
Read More
Next Monday, September 20, 2010, StopAfib.org will be covering the FDA's hearing on dabigatran (Pradaxa), the new alternative to warfarin, and will be "live-tweeting" from the hearing. Get first reports as they happen by following @stopafib on Twitter. If you're already on Twitter, just follow us from the toolbar at the bottom of this page. …
Read More